A Research Study on How UBT251 Affects Levels of Midazolam, Caffeine and Warfarin in the Blood of Participants With Excess Body Weight

NCT07710768 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Overweight

Interventions

DRUG: UBT251
DRUG: Cocktail (Warfarin/Caffeine/Midazolam)

Sponsor

Novo Nordisk A/S